Related Experiment Video
Updated: Jul 14, 2026
05:31
Disruption of the Mouse Blood-Brain Barrier by Small Extracellular Vesicles from Hypoxic Human Placentas
Published on: January 26, 2024
Serum markers for predicting pre-eclampsia
Marc U Baumann1, Nick A Bersinger, Daniel V Surbek
1Department of Obstetrics and Gynecology, University of Berne, Effingerstrasse 102, CH-3010 Berne, Switzerland.
Molecular Aspects of Medicine
|May 29, 2007
Summary
Predicting pre-eclampsia early is crucial. Promising serum markers like placental protein 13 (PP-13) and others, combined with Doppler sonography, show potential for improved prediction and early intervention.
Area of Science:
- Obstetrics and Gynecology
- Maternal-Fetal Medicine
- Biochemical Markers
Background:
- Pre-eclampsia is a significant cause of maternal and newborn morbidity and mortality.
- Current biochemical markers for pre-eclampsia lack proven clinical value.
- Novel markers and screening combinations are under investigation.
Purpose of the Study:
- To review current knowledge on serum markers for predicting pre-eclampsia.
- To identify promising biomarkers for early detection.
- To evaluate the role of combined screening methods.
Main Methods:
- Review of existing literature on serum markers for pre-eclampsia prediction.
- Evaluation of placental protein 13 (PP-13), sFlt-1, PIGF, and sEng.
- Assessment of marker combinations with first-trimester Doppler sonography.
Main Results:
- PP-13, sFlt-1, PIGF, and sEng are identified as the most promising serum markers.
- These markers enable early-stage screening.
- Combination with first-trimester Doppler sonography enhances predictive values and diagnostic performance.
Conclusions:
- The reviewed serum markers offer potential for early pre-eclampsia prediction.
- Combining markers with Doppler sonography improves screening efficacy.
- Large-scale prospective studies are needed to validate clinical utility for early intervention.
Related Concept Videos
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
01:30Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
01:26Nephrotic Syndrome II : Assessment and Medical Management
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
01:24Serum Studies: Renal Function Tests
Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...